Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 3:15:4625-4634.
doi: 10.2147/IJGM.S358094. eCollection 2022.

Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China

Ting Wang  1 , Zhiying Lu  1 , Xiaodan Zhang  1 , Keqin Hua  1
Affiliations

Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China

Ting Wang et al. Int J Gen Med. .

Abstract

Purpose: Clear cell adenocarcinoma of the cervix (CCAC) is a rare pathological type of cervical cancer. This study aimed to report our clinical experience with CCAC treatment and analyze the factors associated with patient survival.

Patients and methods: This single-center study included patients diagnosed with CCAC and treated between 01/2003 and 12/2017 at the Obstetrics and Gynecology Hospital of Fudan University. The patients diagnosed with CCAC that underwent radical resection were included. The Kaplan-Meier method and multivariable Cox regression analysis were performed to determine factors associated with patient survival.

Results: Fifty-four patients were included. None were exposed to diethylstilbestrol. The median follow-up was 96 (13.0, 120.0) months. The median recurrence-free survival (RFS) and overall survival (OS) were 68 and 78 months, respectively. Positive pelvic lymph nodes (HR=2.87, 95% confidence interval [CI] 1.14-7.22, P=0.03), tumor size >4 cm (HR=3.31, 95% CI 1.35-8.12, P=0.01), International Federation of Gynecology and Obstetrics (FIGO) IB2-IIA2 stage (HR=2.49, 95% CI 1.56-3.99, P=0.02), and postoperative therapy (HR=1.73, 95% CI 1.07-2.81, P=0.03) were associated with OS. Multivariable analysis showed that FIGO stage IB2-IIA2 (HR=2.36, 95% CI 1.52-3.68, P<0.01) and lymph node status (HR=3.05, 95% CI 1.12-8.28, P=0.03) were independently associated with OS.

Conclusion: Advanced FIGO stage and positive lymph node status are independently associated with shorter survival in patients with CCAC who were not exposed to diethylstilbestrol. After surgery, chemotherapy and concurrent chemoradiotherapy were not independently associated with the prognosis of patients with CCAC.

Keywords: chemoradiotherapy; clear cell adenocarcinoma of the cervix; radical hysterectomy; uterine cervical neoplasm.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Age distribution of patients with clear cell carcinoma of the cervix (n=54).
Figure 2
Figure 2
Kaplan–Meier curves for overall survival (OS) and recurrence-free survival (RFS) in patients with cervical clear cell carcinoma of the cervix. (A) Median OS times in patients with negative pelvic lymph nodes (PLN) and positive PLN (P=0.018). (B) Median RFS times in patients with negative PLN and positive PLN (P=0.018). (C) Median OS times in patients administered chemotherapy (CT) (n=18) and concurrent chemoradiotherapy (CCRT) (n=26) (P=0.205). (D) Median RFS times in patients administered CT (n=18; not reached) and CCRT (n=26) (P=0.192).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wang D, Zhao C, Fu L, Liu Y, Zhang W, Xu T. Primary Clear Cell Adenocarcinoma of the Cervix: a Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol. Obstet Gynecol Int. 2019;2019:9465375. doi:10.1155/2019/9465375 - DOI - PMC - PubMed
    1. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284(15):878–881. - PubMed
    1. Liu Z, Li J, Gu H, Tu H, Liu G, Liu J. Clear Cell Adenocarcinoma of Uterine Cervix: a Single Institution Retrospective Experience. Front Oncol. 2020;10:532748. - PMC - PubMed
    1. Tornesello ML, Losito S, Benincasa G, et al. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol. 2011;121(1):32–42. - PubMed
    1. Pirog EC, Lloveras B, Molijn A, et al. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Modern Pathol. 2014;27(12):1559–1567. - PubMed